Firma Bearbeiten | CureVac

Firma Bearbeiten | CureVac - the RNA people

Name für Kontakt (*):

E-Mail für Kontakt (*):

Name der Firma (*):

Info:

Info
CureVac is a leading clinical stage biotechnology company in the field of messenger RNA (mRNA) technology with 20 years of expertise in developing and optimizing this versatile molecule for medical purposes.

Geschichte
Founded in 2000 as a spin-off from the University of Tϋbingen in Germany, CureVac is a leading clinical stage biotechnology company in the field of messenger RNA (mRNA) technology with 20 years of expertise in developing and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of cancer therapies, antibody therapies, the treatment of rare diseases, and prophylactic vaccines. CureVac has received significant investments, amongst others from dievini Hopp BioTech holding and the Bill & Melinda Gates Foundation. CureVac has also entered into collaborations with multinational corporations and organizations, including Boehringer Ingelheim, Eli Lilly & Co, Genmab, CRISPR Therapeutics, the Bill & Melinda Gates Foundation, and others. CureVac is headquartered in Tübingen, Germany with sites in Frankfurt and Boston, USA.

Telefon. (*):

Webseite:

Email:

Öffnungszeiten

Montag: -

Dienstag: -

Mittwoch: -

Donnerstag: -

Freitag: -

Samstag: -

Sonntag: -

*** Markieren Sie den Standort auf der Karte

Breite (*):

Läng. (*):

Zustand (*):

Stadt (*):

Adresse 1 (*):

Adresse 2:

Postleitzahl:

Bild: